NCT00100607View on ClinicalTrials.gov

Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis

PHASE2CompletedINTERVENTIONAL
Enrollment

676

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

September 30, 2005

Study Completion Date

September 30, 2005

Conditions
Osteoporosis
Interventions
DRUG

AAE581

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY